scholarly article | Q13442814 |
P819 | ADS bibcode | 2011PLoSO...624296Z |
P356 | DOI | 10.1371/JOURNAL.PONE.0024296 |
P932 | PMC publication ID | 3174162 |
P698 | PubMed publication ID | 21935396 |
P5875 | ResearchGate publication ID | 51659217 |
P2093 | author name string | Fang Liu | |
Yan Zhang | |||
Ying Sun | |||
Yi Yang | |||
Chen Han | |||
Qiaoli Li | |||
Yuan Cao | |||
Jingyi Yang | |||
Maohua Zhong | |||
Benxia He | |||
Dihan Zhou | |||
Huimin Yan | |||
Rong Bao | |||
Yaoming Li | |||
Yaoqing Chen | |||
P2860 | cites work | Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. Chiang Mai HEPS Working Group | Q45752474 |
Expression of AIDS virus envelope gene in recombinant vaccinia viruses | Q45837045 | ||
Vaccinia virus: a selectable eukaryotic cloning and expression vector. 1982 | Q45871103 | ||
Mucosal IgA in exposed, uninfected subjects: evidence for a role in protection against HIV infection | Q46180015 | ||
One time intranasal vaccination with a modified vaccinia Tiantan strain MVTT(ZCI) protects animals against pathogenic viral challenge | Q48358526 | ||
Complications of smallpox vaccination, 1968. | Q54142563 | ||
Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans | Q55883944 | ||
The ‘immunologic advantage’ of HIV-exposed seronegative individuals | Q57997441 | ||
HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals | Q57997711 | ||
Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges | Q59661537 | ||
Mucosal priming with replicative Tiantan vaccinia and systemic boosting with DNA vaccine raised strong mucosal and systemic HIV-specific immune responses | Q64127566 | ||
A stable and highly sensitive 3,3',5,5'-tetramethylbenzidine-based substrate reagent for enzyme-linked immunosorbent assays | Q73387714 | ||
Polarization Restricts Hepatitis C Virus Entry into HepG2 Hepatoma Cells | Q27488433 | ||
The attenuation of vaccinia Tian Tan strain by the removal of the viral M1L-K2L genes. | Q33282808 | ||
A novel replication-competent vaccinia vector MVTT is superior to MVA for inducing high levels of neutralizing antibody via mucosal vaccination. | Q33401609 | ||
Human immunodeficiency virus type 1 infection, mucosal immunity, and pathogenesis and extramural research programs at the National Institutes of Health | Q33547129 | ||
Vaccines and mucosal immunisation | Q34189180 | ||
Mucosal immunity and vaccines | Q34409172 | ||
Recent advances in mucosal vaccines and adjuvants | Q34786990 | ||
Polarized epithelial membrane traffic: conservation and plasticity | Q35096249 | ||
Immunobiology of mucosal HIV infection and the basis for development of a new generation of mucosal AIDS vaccines | Q35696885 | ||
Discovery of novel immunostimulants by dendritic-cell-based functional screening. | Q35848403 | ||
Poxvirus expression vectors | Q36094701 | ||
Vaccinia virus entry, exit, and interaction with differentiated human airway epithelia | Q36098912 | ||
Protective attenuated lentivirus immunization induces SIV-specific T cells in the genital tract of rhesus monkeys. | Q36105923 | ||
The M protein of vesicular stomatitis virus associates specifically with the basolateral membranes of polarized epithelial cells independently of the G protein | Q36219630 | ||
Recombinant poxviruses as mucosal vaccine vectors | Q36287573 | ||
Willingness of Chinese injection drug users to participate in HIV vaccine trials. | Q37389297 | ||
Human immunodeficiency virus envelope protein determines the site of virus release in polarized epithelial cells | Q37505667 | ||
Strategies for optimizing targeting and delivery of mucosal HIV vaccines | Q37554135 | ||
Gender differences in human immunodeficiency virus type 1-specific CD8 responses in the reproductive tract and colon following nasal peptide priming and modified vaccinia virus Ankara boosting | Q37596422 | ||
Vesicular stomatitis virus glycoprotein does not determine the site of virus release in polarized epithelial cells | Q39683224 | ||
Measles virus preferentially transduces the basolateral surface of well-differentiated human airway epithelia | Q39748031 | ||
Protection of mice from respiratory Sendai virus infections by recombinant vaccinia viruses | Q39877929 | ||
Virus Entry and Release in Polarized Epithelial Cells | Q40431595 | ||
Polarized entry and release of Junin virus, a New World arenavirus | Q40510682 | ||
Three-dimensional analysis of post-Golgi carrier exocytosis in epithelial cells | Q40675232 | ||
Expression of caveolin-1 and polarized formation of invaginated caveolae in Caco-2 and MDCK II cells. | Q41045297 | ||
Vesicular stomatitis virus infects and matures only through the basolateral surface of the polarized epithelial cell line, MDCK. | Q41527546 | ||
HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers | Q43976669 | ||
Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease | Q44718436 | ||
Pathogenicity and immunogenicity of recombinant Tiantan Vaccinia Virus with deleted C12L and A53R genes | Q45394220 | ||
Tissue distribution of the Ankara strain of vaccinia virus (MVA) after mucosal or systemic administration | Q45723808 | ||
Pathogenesis of experimental vesicular stomatitis virus (New Jersey serotype) infection in the deer mouse (Peromyscus maniculatus). | Q45736399 | ||
Replication and budding of simian immunodeficiency virus in polarized epithelial cells | Q45749978 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Vaccinia virus | Q1986297 |
(S)-(−)-colchicine | Q326224 | ||
P304 | page(s) | e24296 | |
P577 | publication date | 2011-09-15 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Unpolarized release of vaccinia virus and HIV antigen by colchicine treatment enhances intranasal HIV antigen expression and mucosal humoral responses | |
P478 | volume | 6 |
Q28482446 | Anti-HIV-1 activity of a new scorpion venom peptide derivative Kn2-7 |
Q37505389 | Antigen replacement of domains D2 and D3 in flagellin promotes mucosal IgA production and attenuates flagellin-induced inflammatory response after intranasal immunization |
Q34171543 | Attenuation of vaccinia Tian Tan strain by removal of viral TC7L-TK2L and TA35R genes |
Q34809121 | Deletion of C7L and K1L genes leads to significantly decreased virulence of recombinant vaccinia virus TianTan |
Q64359365 | Intranasal immunization with recombinant Vaccinia virus Tiantan harboring Zaire Ebola virus gp elicited systemic and mucosal neutralizing antibody in mice |
Q40046446 | Second-generation Flagellin-rPAc Fusion Protein, KFD2-rPAc, Shows High Protective Efficacy against Dental Caries with Low Potential Side Effects |
Q42244263 | Spectral analysis and slow spreading dynamics on complex networks |
Search more.